Nancy Lin, MD, explains how an AI model compares with genomic classifiers in HR+/HER2- early breast cancer, with implications for cost and access. 259 Prospect Plains Rd, Bldg H Cranbury, NJ 08512 ...
Nancy Lin, MD, explains how an AI model compares with genomic classifiers in HR+/HER2- early breast cancer, with implications for cost and access. The study takes aim at one of the friction points in ...
“This is the first randomized trial to demonstrate an overall survival benefit for patients with brain metastases, which I think is very significant,” said Dr. Nancy U. Lin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results